Brig Center for Cancer Care and Survivorship — Knoxville, Tennessee

Brig Center for Cancer Care and Survivorship is a clinical research site located in Knoxville, Tennessee, United States 37909.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Brig Center for Cancer Care and Survivorship has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer, HER2-positive Breast Cancer, Early Breast Cancer.

Sponsors: Daiichi Sankyo, Seagen, a wholly owned subsidiary of Pfizer, Stemline Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Knoxville

Browse all research sites in Tennessee · View every site in Knoxville

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Brig Center for Cancer Care and Survivorship?

Brig Center for Cancer Care and Survivorship has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Brig Center for Cancer Care and Survivorship conducted?

Brig Center for Cancer Care and Survivorship has 4 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, HER2-positive Breast Cancer, Early Breast Cancer.

Is Brig Center for Cancer Care and Survivorship accredited by Crixeo Clinical Trials?

Brig Center for Cancer Care and Survivorship has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Brig Center for Cancer Care and Survivorship?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.